Why Australia?

The Australian life sciences industry has thrived over the past decade. Underpinned by strong medical research and a collaborative culture, our industry is driving transformative innovations in health.

Australia’s competitive advantage

Australia sees investors take innovations from the lab, through manufacturing and into clinical settings with ease. Australia’s competitive advantage is underpinned by:

• An established healthcare system supported by globally recognised regulators.
• A vibrant innovation ecosystem with expertise and world-class infrastructure.
• Outstanding clinical trial capabilities, with streamlined regulatory pathways to expedite studies.
• Significant government support, including an R&D tax offset of up to 43.5% and A$21.5 billion in support funds for life sciences.
• An export-driven economy with 18 free trade agreements.